|
抗凝血酶治疗弥散性血管内凝血的研究进展 |
| |
nbsp;(AT Ⅲ) replacement therapy in patients with sepsis and/or postsurgical complications: a controlled doubleblind, randomized, multicenter study[J].Intensive Care Med,1998,24(4):336342.
[18] WARREN BL,EID A,SINGER P,et al.Highdose antithrombin in severe sepsis[J].JAMA,2001,286:18691878.
[19] TAYLOR FB,TOH CH,HOOTS WK,et al.Towards definition,clinical and laboratory criteria,and a scoring system for disseminated intravascular coagulation[J].Thromb Haemost,2001,86(5):13271330.
[20] KIENAST J,JUERS CM,WIEDERMANN J,et al.Treatment effects of highdose antithrombin without concomitant heparin in patients with severe sepsis with or without disseminated intravascular coagulation[J]. Thromb Haemost,2006,4:9097.
上一页 [1] [2] [3] [4] [5] [6]
上一个医学论文： CD 40 CD 40L与血栓性疾病研究进展
下一个医学论文： 产科弥散性血管内凝血
|
|
|
您现在的位置： 绿色健康网 >> 医学论文 >> 内科论文 >> 正文